The company had almost no realistic pipeline. We rented one facility - now we own one and we rent one. We had no sales force - today we have a very aggressive sales force that got us 20% of the adderall Market in 2 years. We had no distribution today we have a state of the art distribution. We had a couple of products bringing $6 Million per year - today we have a bunch of needle movers We had just manufacturing and expensive R&D.- today we have best of breed manufacturing with great equipment and a low cost R&D in India. We had many partners who made money on our back - today we have only one partner that made this possible: MIKAH !!!
Not sure we were FDA and DEA approved site back then - maybe only FDA - and the number of QA inspections that we passed is countless...
----------
That translates to $0.82 - $0.1.04 over 1 billion shares.
During these years, company's revenue increased by 10 times (??) to $180 million (May be more than 10 times)
The company has been far more profitable, with a lot more possibilities in pipeline.
This should translate into SP increase by 150% JMHO. This translates to a mean value of about $2.30
Add some 30% premium keeping in view all future possibilities (it ought to be more). This ought to bring the valuation to about $3.00 on the conservative side JMHO
Please note that this is purely hypothetical calculation. Just some logical guessing of numbers.
Market Data 
Markets 
AI
